Wolters Kluwer Health Appoints Cathy Wolfe President & CEO of

Wolters Kluwer Health Appoints Cathy Wolfe President & CEO of Medical
PHILADELPHIA, PA -- (Marketwire) -- 10/15/12 --  Wolters  Kluwer
Health, a leading global provider of information, business
intelligence and point-of-care solutions for
the healthcare industry,
today announced the appointment of Cathy Wolfe as President & CEO of
its Medical Research business, effective January 1, 2013.
well-known brands of Ovid and Lippincott Williams & Wilkins (LWW),
Kluwer Health Medical Research provides innovative online
research services as
well as leading medical, clinical and nursing
journal publishing solutions for
healthcare practitioners, students
and research professionals in more than 180
A veteran of Wolters Kluwer, Wolfe has served as the CEO of Wolters
Kluwer U.K.
since 2007. She has been with the company since 1996,
including key leadership
positions in the U.S. and the U.K., and has
a track record of delivering strong
results and innovation. During
her time at Wolters Kluwer, Wolfe has led numerous large and complex
technology and product development initiatives that
have resulted in
the launch of innovative digital solutions that combine software,
services and information. 
Wolfe will succeed Karen Abramson, who led the Wolters Kluwer Health
Research business since 2006 and was recently appointed as
President and CEO of Wolters Kluwer Tax & Accounting's CCH Business
Unit effective in September. Wolters Kluwer Health President & CEO
Bob Becker will continue to lead the Medical Research Business Unit
until Wolfe assumes the role in January. 
"We are thrilled to welcome Cathy to our Health division leadership
team," said
Becker. "Her global expertise combined with her proven
track record of developing and launching innovative products in both
electronic and print formats will position our Medical Research
business to continue its focus on
delivering leading-edge solutions
to meet the evolving needs of our global customers." 
While CEO of Wolters Kluwer U.K., Wolfe led the business to strong
results and
became known for driving customer-focused innovation and
operational efficiencies. Prior to becoming CEO of the U.K. business,
Wolfe served as Vice
President of Tax & Accounting publishing group
for CCH while based in the Chicago area. 
"I am excited to join the Health team," said Wolfe. "Wolters Kluwer
Health and
its Medical Research business are on the forefront of
developing and delivering
solutions that help our global customers
improve patient care and fuel new discoveries. This is a critical
time in healthcare, and I'm excited to be part
of this ongoing
transformation to deliver the best research and information
impacts care." 
Wolters Kluwer Health is a global provider of information, business
and point-of-care solutions for the healthcare industry,
with leading brands
including Lippincott Williams & Wilkins, Ovid(R),
Pharmacy OneSource(R),
Lexicomp and UpToDate(R), among others. Its
customers include professionals,
students, institutions and
organizations across the globe. Products and services
industry-leading textbooks and journals, clinical information,
electronic medical, scientific and academic research solutions,
clinical decision support solutions and evidence-based content that is
easily accessible
at the point of care. 
For more information on Wolters Kluwer Health, visit
About Wolters Kluwer Health 
Wolters Kluwer Health is a leading global provider of information,
business intelligence and point-of-care solutions for the healthcare
industry. Serving
more than 150 countries and territories worldwide,
Wolters Kluwer Health's customers include professionals, institutions
and students in medicine, nursing,
allied health and pharmacy. Major
brands include Lippincott Williams & Wilkins,
Ovid(R), UpToDate(R),
Medi-Span(R), Facts & Comparisons(R), Pharmacy
Lexicomp(R) and ProVation(R) Medical. 
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading
global information services company. Wolters Kluwer had 2011 annual
revenues of EUR3.4
billion ($4.7 billion), employs approximately
19,000 people worldwide, and maintains operations in over 40
countries across Europe, North America, Asia
Pacific, and Latin
Forward-looking Statements 
This press release contains forward-looking statements. These
statements may be identified by words such as "expect", "should",
"could", "will", "shall" and
similar expressions. Wolters Kluwer
cautions that such forward-looking statements are qualified by
certain risks and uncertainties that could cause
actual results and
events to differ materially from what is contemplated by
forward-looking statements. Factors which could cause actual
results to differ
from these forward-looking statements may include,
without limitation, general
economic conditions; conditions in the
markets in which Wolters Kluwer is engaged; behavior of customers,
suppliers, and competitors; technological developments; the
implementation and execution of new ICT systems or outsourcing; and
legal, tax, and regulatory rules affecting Wolters
businesses, as well as risks related to mergers,
acquisitions, and divestments.
In addition, financial risks such as
currency movements, interest rate fluctuations, liquidity, and credit
risks could influence future results. The
foregoing list of factors
should not be construed as exhaustive. Wolters Kluwer
disclaims any
intention or obligation to publicly update or revise any
forward-looking statements, whether as a result of new information,
future events, or otherwise. 
PDF version of Press Release: 
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants
(i) the releases contained herein are protected by copyright and    
other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and     
originality of the information contained therein. 
Source: Wolters Kluwer NV via Thomson Reuters ONE 
Robert Dekker
+1 (215) 521 8928
Meg Geldens
+31 (0)172 641 407
Press spacebar to pause and continue. Press esc to stop.